Protagonist Therapeutics
Price & Volume
Stats
See moreOpen | $53.89 |
Previous Close | $53.75 |
Day Range | $53.47-$54.74 |
52W Range | $33.31-$60.60 |
Market Cap | $3.1B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $209.1M |
Revenue Growth (YoY) | 33.1% |
Gross Profit (12 Mos) | $209.1M |
Diluted EPS | $0.73 |
News
See moreYahoo Finance • 15 days ago
Protagonist therapeutics CEO Patel sells $570k in stock
Yahoo Finance • 15 days ago
XSMO's Underlying Holdings Could Mean 15% Gain Potential
Yahoo Finance • 22 days ago
Protagonist Announces Submission of NDA for First Icotrokinra U.S. FDA Approval Aiming to Revolutionize Treatment Paradigm for Adults and Adolescents with Plaque Psoriasis
Yahoo Finance • last month
Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?
About
CEO | Dr. Dinesh V. Patel Ph.D. |
CFO | Mr. Asif Ali |
Address | 7707 Gateway Boulevard, Newark, CA, United States, 94560 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 130 |
